ZIVO Bioscience - ZIVO Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $9.00
  • Forecasted Upside: 232.40 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$2.71
▲ +0.03 (1.12%)

This chart shows the closing price for ZIVO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New ZIVO Bioscience Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ZIVO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ZIVO

Analyst Price Target is $9.00
▲ +232.40% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for ZIVO Bioscience in the last 3 months. The average price target is $9.00, with a high forecast of $9.00 and a low forecast of $9.00. The average price target represents a 232.40% upside from the last price of $2.71.

This chart shows the closing price for ZIVO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in ZIVO Bioscience.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/12/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/9/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/9/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/7/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/5/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/4/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/4/2022

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/15/2021Maxim GroupInitiated CoverageBuy$9.00
(Data available from 12/4/2017 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/8/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/7/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/7/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/6/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/5/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/5/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/4/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/4/2022

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
ZIVO Bioscience logo
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is based in Bloomfield Hills, Michigan.
Read More

Today's Range

Now: $2.71
Low: $2.71
High: $2.71

50 Day Range

MA: $2.98
Low: $2.62
High: $3.33

52 Week Range

Now: $2.71
Low: $2.37
High: $4.60

Volume

1,657 shs

Average Volume

7,964 shs

Market Capitalization

$25.51 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.02

Frequently Asked Questions

What sell-side analysts currently cover shares of ZIVO Bioscience?

The following Wall Street sell-side analysts have issued reports on ZIVO Bioscience in the last year: Maxim Group.
View the latest analyst ratings for ZIVO.

What is the current price target for ZIVO Bioscience?

1 Wall Street analysts have set twelve-month price targets for ZIVO Bioscience in the last year. Their average twelve-month price target is $9.00, suggesting a possible upside of 232.4%. Maxim Group has the highest price target set, predicting ZIVO will reach $9.00 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $9.00 for ZIVO Bioscience in the next year.
View the latest price targets for ZIVO.

What is the current consensus analyst rating for ZIVO Bioscience?

ZIVO Bioscience currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ZIVO will outperform the market and that investors should add to their positions of ZIVO Bioscience.
View the latest ratings for ZIVO.

What other companies compete with ZIVO Bioscience?

How do I contact ZIVO Bioscience's investor relations team?

ZIVO Bioscience's physical mailing address is 2804 ORCHARD LAKE ROAD SUITE 202, KEEGO HARBOR MI, 48320. The biotechnology company's listed phone number is (248) 452-9866 and its investor relations email address is [email protected] The official website for ZIVO Bioscience is www.zivobioscience.com. Learn More about contacing ZIVO Bioscience investor relations.